Xinbo Zhou

644 total citations
21 papers, 525 citations indexed

About

Xinbo Zhou is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Xinbo Zhou has authored 21 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Epidemiology. Recurrent topics in Xinbo Zhou's work include Adipose Tissue and Metabolism (7 papers), Metabolism, Diabetes, and Cancer (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xinbo Zhou is often cited by papers focused on Adipose Tissue and Metabolism (7 papers), Metabolism, Diabetes, and Cancer (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Xinbo Zhou collaborates with scholars based in China, Czechia and United Kingdom. Xinbo Zhou's co-authors include Qingquan Ma, Linlin Hu, Anshan Shan, Jiayi Chen, Song Li, Jia‐Liang Zhu, Qingwei Meng, Yaping Wang, Changxuan Shao and Lili Wang and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, British Journal of Pharmacology and Journal of Dairy Science.

In The Last Decade

Xinbo Zhou

20 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinbo Zhou China 15 314 171 85 51 47 21 525
Yung‐Hsi Kao Taiwan 10 181 0.6× 99 0.6× 106 1.2× 64 1.3× 46 1.0× 23 652
Bingrun Liu China 11 306 1.0× 161 0.9× 49 0.6× 57 1.1× 42 0.9× 13 743
Praveen Kumar Kalavagunta China 10 311 1.0× 141 0.8× 112 1.3× 27 0.5× 45 1.0× 15 638
Milica Vujičić Serbia 16 212 0.7× 114 0.7× 72 0.8× 68 1.3× 23 0.5× 27 634
Walaa Wadie Egypt 15 293 0.9× 85 0.5× 68 0.8× 35 0.7× 63 1.3× 46 665
Renjie Shi China 13 321 1.0× 135 0.8× 42 0.5× 29 0.6× 94 2.0× 27 598
Farhana Ferdousi Japan 16 179 0.6× 65 0.4× 58 0.7× 39 0.8× 55 1.2× 46 617
Hongyu Qi China 14 340 1.1× 71 0.4× 73 0.9× 29 0.6× 19 0.4× 33 609
Yingjie Dong China 13 263 0.8× 103 0.6× 62 0.7× 30 0.6× 29 0.6× 33 591

Countries citing papers authored by Xinbo Zhou

Since Specialization
Citations

This map shows the geographic impact of Xinbo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbo Zhou more than expected).

Fields of papers citing papers by Xinbo Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinbo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbo Zhou. The network helps show where Xinbo Zhou may publish in the future.

Co-authorship network of co-authors of Xinbo Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xinbo Zhou. A scholar is included among the top collaborators of Xinbo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinbo Zhou. Xinbo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Xinbo, Junjie Zhang, Yutong Sun, et al.. (2023). Glutamine Ameliorates Liver Steatosis via Regulation of Glycolipid Metabolism and Gut Microbiota in High-Fat Diet-Induced Obese Mice. Journal of Agricultural and Food Chemistry. 71(42). 15656–15667. 12 indexed citations
4.
Zhang, Zhengwei, Chunsheng Gao, Heng Zhang, et al.. (2022). Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota. Acta Pharmaceutica Sinica B. 12(8). 3298–3312. 90 indexed citations
5.
Chen, Jiayi, Bo Sun, Xinbo Zhou, et al.. (2022). Threonine supplementation prevents the development of fat deposition in mice fed a high-fat diet. Food & Function. 13(14). 7772–7780. 15 indexed citations
6.
Zhou, Xinbo, Jiayi Chen, Bo Sun, et al.. (2021). Leucine, but not isoleucine or valine, affects serum lipid profiles and browning of WAT in mice. Food & Function. 12(15). 6712–6724. 24 indexed citations
7.
Li, Wenzhen, Yifan Wang, Xinbo Zhou, et al.. (2021). The anti-tumor efficacy of 20(S)-protopanaxadiol, an active metabolite of ginseng, according to fasting on hepatocellular carcinoma. Journal of Ginseng Research. 46(1). 167–174. 16 indexed citations
10.
Song, Shan, Yuhan Wang, Jinying Wei, et al.. (2020). TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy. Experimental Cell Research. 388(2). 111862–111862. 28 indexed citations
11.
Ma, Qingquan, Xinbo Zhou, Linlin Hu, et al.. (2020). Threonine, but Not Lysine and Methionine, Reduces Fat Accumulation by Regulating Lipid Metabolism in Obese Mice. Journal of Agricultural and Food Chemistry. 68(17). 4876–4883. 60 indexed citations
12.
Song, Shan, Yonghong Shi, Shuai Wang, et al.. (2019). Thioredoxin‐interacting protein deficiency alleviates phenotypic alterations of podocytes via inhibition of mTOR activation in diabetic nephropathy. Journal of Cellular Physiology. 234(9). 16485–16502. 27 indexed citations
13.
Chen, Wei, Liu C, Xinbo Zhou, et al.. (2017). Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice. Frontiers in Pharmacology. 8. 707–707. 26 indexed citations
14.
Gao, Hongmei, Shengguo Zhao, Nan Zheng, et al.. (2017). Combination of histidine, lysine, methionine, and leucine promotes β-casein synthesis via the mechanistic target of rapamycin signaling pathway in bovine mammary epithelial cells. Journal of Dairy Science. 100(9). 7696–7709. 24 indexed citations
15.
Qi, Xin, Peng Li, Cuiping Shi, et al.. (2017). Magnetic tweezers for the mechanical research of DNA at the single molecule level. Analytical Methods. 9(39). 5720–5730. 18 indexed citations
16.
Jiang, Ning, Zhiyong Xiao, Junping Cheng, et al.. (2016). Effects of poly (ADP-ribose) polymerase-1 (PARP-1) inhibition on sulfur mustard-induced cutaneous injuries in vitro and in vivo. PeerJ. 4. e1890–e1890. 18 indexed citations
17.
Xie, X. C., Xinbo Zhou, Wei Chen, et al.. (2014). L312, a novel PPARγ ligand with potent anti-diabetic activity by selective regulation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1850(1). 62–72. 27 indexed citations
18.
Wang, Xiaokui, et al.. (2013). Improved synthesis of PARP antagonist veliparib. Zhongguo yaowu huaxue zazhi. 476–479. 1 indexed citations
19.
Zhang, Ning, Xinbo Zhou, Xiaolin Zhou, et al.. (2013). C333H Ameliorated Insulin Resistance through Selectively Modulating Peroxisome Proliferator-Activated Receptor γ in Brown Adipose Tissue of db/db Mice. Biological and Pharmaceutical Bulletin. 36(6). 980–987. 8 indexed citations
20.
Chen, Wei, Xinbo Zhou, Hongying Liu, et al.. (2009). P633H, a novel dual agonist at peroxisome proliferator‐activated receptors α and γ, with different anti‐diabetic effects in db/db and KK‐Ay mice. British Journal of Pharmacology. 157(5). 724–735. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026